Lenzing Biocel Paskov made a net profit of CZK 1,111 mil with revenues of CZK 5,285 mil in 2019, down by 21.6% and up by 0.683%, respectively, compared to the previous year. This translates into a net margin of 21.0%.
Historically, between 2007 - 2019, the firm’s net profit reached a high of CZK 1,621 mil in 2017 and a low of CZK -99.0 mil in 2012. Since 2014, the firm's net profit has increased 93.1% or 14.1% a year on average.
On the operating level, EBITDA reached CZK 1,938 mil, down 6.95% compared to the previous year. Over the last five years, company's EBITDA has risen 6.46% a year on average.
You can see all the company’s data at Lenzing Biocel Paskov profile, or you can download a report on the company in the report section.
Helgi Library 
